Evidence map›Paper›PMID 38385872›Full record

ArticleBriefings in bioinformatics2024

ChemMORT: an automatic ADMET optimization platform using deep learning and multi-objective particle swarm optimization.

Jia-Cai Yi, Zi-Yi Yang, Wen-Tao Zhao, Zhi-Jiang Yang, Xiao-Chen Zhang, Cheng-Kun Wu, Ai-Ping Lu, Dong-Sheng Cao

Open access · goldAbstract read
In one paragraph

Article in Briefings in bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Jia-Cai YiSchool of Computer Science, National University of Defense Technology, Changsha 410073, Hunan, PR China.ORCID 0000-0001-6823-1882
Zi-Yi YangXiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, Hunan, P. R. China.
Wen-Tao ZhaoSchool of Computer Science, National University of Defense Technology, Changsha 410073, Hunan, PR China.
Zhi-Jiang YangXiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, Hunan, P. R. China.
Xiao-Chen ZhangSchool of Computer Science, National University of Defense Technology, Changsha 410073, Hunan, PR China.ORCID 0000-0002-7187-435X
Cheng-Kun WuState Key Laboratory of High-Performance Computing, Changsha 410073, Hunan, PR China.
Ai-Ping LuInstitute for Advancing Translational Medicine in Bone and Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, P. R. China.
Dong-Sheng CaoXiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, Hunan, P. R. China.ORCID 0000-0003-3604-3785
Central South University · CNNational University of Defense Technology · CNHong Kong Baptist University · HK

Funding

Excellent Youth Foundation of Hunan Province 2021JJ10068Foundation of State Key Laboratory of HPCL 2023-KJWHPCL-01HKBU Strategic Development Fund project SDF19-0402-P02Key scientific research projects in higher education institutions of Henan Province 24A520036National Key Research and Development Program of China 2022YFA1004303National Science Foundation of China 22173118Science Foundation for Indigenous Innovation of National University of Defense Technology 23-ZZCX-JDZ-08
6 · The paper itself

Abstract

Drug discovery and development constitute a laborious and costly undertaking. The success of a drug hinges not only good efficacy but also acceptable absorption, distribution, metabolism, elimination, and toxicity (ADMET) properties. Overall, up to 50% of drug development failures have been contributed from undesirable ADMET profiles. As a multiple parameter objective, the optimization of the ADMET properties is extremely challenging owing to the vast chemical space and limited human expert knowledge. In this study, a freely available platform called Chemical Molecular Optimization, Representation and Translation (ChemMORT) is developed for the optimization of multiple ADMET endpoints without the loss of potency (https://cadd.nscc-tj.cn/deploy/chemmort/). ChemMORT contains three modules: Simplified Molecular Input Line Entry System (SMILES) Encoder, Descriptor Decoder and Molecular Optimizer. The SMILES Encoder can generate the molecular representation with a 512-dimensional vector, and the Descriptor Decoder is able to translate the above representation to the corresponding molecular structure with high accuracy. Based on reversible molecular representation and particle swarm optimization strategy, the Molecular Optimizer can be used to effectively optimize undesirable ADMET properties without the loss of bioactivity, which essentially accomplishes the design of inverse QSAR. The constrained multi-objective optimization of the poly (ADP-ribose) polymerase-1 inhibitor is provided as the case to explore the utility of ChemMORT.

Indexed as

Deep LearningDrug DevelopmentDrug DiscoveryHumansPoly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) Polymerase InhibitorsADMET evaluationdeep learninginverse QSARlead optimizationparticle swarm optimizationreversible molecular representationsubstructure modification

Identifiers

PMID38385872
PMCPMC10883642
OpenAlexW4392021329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.